血清铁蛋白、谷氨酰转肽酶、腺苷脱氨酶和5′-核苷酸酶联合检测对肝癌的诊断价值

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (458 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the diagnostic value of serum ferritin (SF), glutamyltranspeptidase (GGT), adenosine deaminase (ADA) and 5′-nucleotidase (5′-NT) in the diagnosis of liver cancer. Methods A total of 200 patients with liver cancer treated in Xinjiang Medical University Affiliated Hospital of Traditional Chinese Medicine from April 2020 to March 2022 were selected as the liver cancer group, and 195 patients with benign liver tumors during the same period were selected as the benign group. The levels of SF, GGT, ADA and 5′-NT were measured and compared between the two groups. The pathological diagnosis results were used as the gold standard to calculate the consistency, sensitivity, specificity and accuracy of SF, GGT, ADA and 5′-NT in single and combined diagnosis of liver cancer. Results The levels of SF, GGT, ADA and 5′-NT in liver cancer group were higher than those in benign group, and the differences were statistically significant (P<0.05). Taking pathological diagnosis results as the gold standard, the consistency between SF+GGT+ADA+5′-NT and pathological results was better than that of SF, GGT, ADA and 5′-NT. The sensitivity and accuracy of SF+GGT+ADA+5′-NT combined diagnosis were higher than those of SF, GGT, ADA and 5′-NT alone,the differences were statistically significant (P<0.005). There was no statistically significant difference in the specificity of SF, GGT, ADA and 5′-NT in the diagnosis of hepatocellular carcinoma (P>0.005). There were no statistically significant differences in the sensitivity, specificity and accuracy of SF, GGT, ADA and 5′-NT (P>0.005). Conclusion The serum levels of SF, GGT, ADA and 5′-NT in patients with liver cancer are increased, and the combined detection of SF, GGT, ADA and 5′-NT can improve the diagnostic sensitivity of liver cancer, and the diagnostic efficiency is high.

Key words： Liver cancer Ferritin Glutamyl transpeptidase Adenosine deaminase 5′-nucleotidase Diagnostic efficiency

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I24/95

[1]	孔杰，李辉，曾雪燕，等.原发性肝癌区域淋巴结转移的临床病理特点及预后分析[J].中华肿瘤防治杂志，2022，29（4）：290-295，301.
[2]	程书平，李明，谭诗云.血清AFP、PIVKA-Ⅱ、GGT、GGT/ALT 检测对早期原发性肝癌的诊断价值[J].山东医药，2021，26（1）：61-65.
[3]	单永锋，郁皓，刘慧，等.铁蛋白、甲胎蛋白和甲胎蛋白异质体检测对肝癌诊断及疗效评估的价值[J].医学临床研究，2021，38（3）：396-398，402.
[4]	段飞，周刚，张秀辉，等.血清AFP、TSGF、GP73 及GGT 联合MSCT 检查对原发性肝癌的诊断价值分析[J].中国CT和MRI 杂志，2021，19（10）：101-103.
[5]	费梦雪，农清清，赵惠柳，等.十项常用肝功指标对早期原发性肝癌的诊断价值[J].医学理论与实践，2019，32（8）：1123-1125，1134.
[6]	李长贤，张慧，吴晓峰，等.不同中国肝癌分期肝癌根治性切除术后的临床效果及预后因素分析[J].中华外科杂志，2021，59（2）：134-143.
[7]	杨启，吕新远，万春.原发性肝癌的超声特征及联合AFP、CEA 的诊断价值[J].中国现代普通外科进展，2021，24（1）：61-63.
[8]	李采霖，王芳，阮佳泉，等.CDU 与血清AFP 检测在原发性肝癌患者诊断中的比较研究[J].西南国防医药，2020，30（12）：1091-1094.
[9]	胡春梅，童玲，刘霞，等.血清异常凝血酶原、甲胎蛋白、铁蛋白和血清淀粉样蛋白A 联合检测在原发性肝癌中的应用价值[J].国际检验医学杂志，2022，43（8）：967-972.
[10]	周永祥，首峰，张景俊，等.TSGF、GGT 联合、VEGF 检测对原发性肝癌TACE 疗效的预测价值[J].分子诊断与治疗杂志，2021，13（3）：466-469，473.
[11]	郭瑾.临床检验生化指标在病毒性肝病患者诊断中的价值研究[J].临床研究，2020，28（9）：153-155.
[12]	苏勇，陆奎英，王永斌.不同类型肝胆疾病肝损伤酶活性联合检测的诊断价值[J].肝胆外科杂志，2021，29（1）：42-45.
[13]	刘少平，余卉.血清MAO、5′-NT、GGT 检测在诊断原发性癌中的价值[J].实用癌症杂志，2020，35（2）：223-225，229.
[14]	马智星，农清清，赵惠柳，等.4 项生化指标联合检测在原发性肝癌诊断中的应用[J].广西医科大学学报，2020，37（2）：235-239.
[15]	唐亮，郑晓东，郑佳连.光谱CT、MRI 以及血清相关指标与肿瘤标志物检测在原发性肝癌的诊断价值[J].中国医学装备，2021，18（9）：62-66.
[16]	袁燚.原发性肝癌介入治疗患者感知控制和创伤后应激障碍的关系研究[J].中国医药科学，2021，11（22）：157-161.
[17]	张丹霞，张永虎，桂若虎，等.甲胎蛋白、甲胎蛋白异质体与肿瘤坏死因子α 检测在原发性肝癌诊断中的应用价值[J].中国当代医药，2021，28（26）：223-225，229.
[18]	卓雪芽，吕微风.血清同型半胱氨酸、α-L-岩藻糖苷酶、血清铁蛋白检测在原发性肝癌诊断中的应用[J].中国医药科学，2020，10（5）：154-156.